T1DX-QI Learning Session 2022; 11/7/2022 - 11/8/2022

PLEASE NOTE: Due to the cancellation of Breakout Session 4, scheduled from 2-3pm on 11/8/22, the final accreditation hours have been adjusted to 12.5 AMA PRA Category 1 Credits™ and 12.5 CNE Contact hours. Learners should claim only the credit commensurate with the extent of their participation in the activity.

Thank you for understanding.

We hope all attendees were able to arrive home quickly and safely.  


By the end of this learning session, we want participants to:

Know: We are making a positive impact on diabetes health outcomes through our interventions.

Feel: Energized that you have the tools to effectively mobilize your team and optimistic about the resources shared across the QI Collaborative.

Do: Implement new PDSA cycles and share results with the QI Collaborative.

Target Audience

This activity has been designed to meet the educational needs of Endocrinologists, PCPs, pharmacists, physician assistants, nurses, nurse practitioners, QI Specialists who are involved in the care and treatment of patients with Type 1 diabetes. 



Learning Objectives

At the conclusion of this activity, participants will be able to:

  1. Understand the future of novel therapies, interventions, quality improvements, and solutions to today’s diabetes care challenges
  2. Understand how gaps in population health needs can be improved over the next 3 years
  3. Apply the strategies of the T1DX-QI Equity Framework to improve diabetes health outcomes for BIPOC T1D and T2D patients
  4. Describe expectations for patient care and patient engagement and how to co-design care with patients.


Course summary
Available credit: 
  • 12.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 12.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 12.50 ANCC
    • 8.67 ANCC Pharmacology
  • 12.50 Participation
Course opens: 
Course expires: 

Day One: Nov 7th, 2022

7:00 – 8:00 am  Breakfast

8:00 – 8:15 am   Greetings, Logistics, and Agenda Overview (Brickell)
Nicole Rioles, MA

8:15 – 8:35 am   Introduction from University of Miami (Brickell)
Janine Sanchez, MD and Francesco Vendrame, MD, PhD

8:35 – 9:20 am  QI Collaborative Accomplishments (Brickell)
Osagie Ebekozien, MD, MPH

9:20 – 9:40 am  T1D Exchange Update (Brickell)
Dave Walton, MBA

9:40 – 9:50 am Journal of Diabetes Partnership (Brickell)
Robert Rapaport, MD

9:50 – 10:10 am Break 

10:10 – 10:55 am Building QI Leadership (Brickell)
Grace Nelson, MD, Devin Steenkamp, MBChB,
Alisha Virani, MS, RD, CDCES, LD, Emily Coppedge, NP

Facilitated by Todd Alonso, MD


11:05 – 12:05 pm Breakout Session #1

Making Device Access Equitable (Orchid C)
Facilitated by Alexis McKee, MD, CDCES

  1. Interventions to Improve Technology Equity in Young Adults (YA) with Type 1 Diabetes (TID), Priyanka Mathias, MD
  2. Increasing Accessibility to CGM in an Equitable Fashion, Blake Adams, BSN, RN
  3. Continuing improvement of health equity: use of continuous glucose monitoring technology among youth with type 1 diabetes, Kajal Gandhi, DO, MPH
  4. 2021 T1D Exchange QI Clinic Practice Survey: Clinic Staffing and Structure for Adult and Pediatric Diabetes Clinics, Mary Pat Gallagher, MD

Improving Device Access (Orchid B)
Facilitated by Donna Eng, MD

  1. Reducing Disparities in CGM Use for Youth with Type 1 Diabetes, Elizabeth Mann, MD
  2. Increasing Access to Continuous Glucose Monitor: Addressing Health Disparities in Type 1 Diabetes, Christy Byer-Mendoza, MSN, RN, CPN, CNS
  3. Improving Access to Continuous Glucose Monitors for Patients with T1D in a Safety Net Hospital Clinic, Alisha Virani, MS, RD, CDCES, LD
  4. Improving Continuous Glucose Monitoring Use in Adolescents and Young Adults, Faisal Malik, MD MSHS

Population Health & Data Dashboard (Orchid D)
Facilitated by Brian Miyazaki, MD

  1. Towards risk-based management of type 1 diabetes (T1D): Developing a population health dashboard based on performing diabetes self-management habits, Craig Vandervelden, PhD (virtual)
  2. Creation of a Diabetes Data Dock to Integrate, Improve, and Analyze Diverse Data Sources and Facilitate Continuous Learning and Improvement, Brent Lockee (virtual)
  3. The Role of Certified Diabetes Care and Education Specialists in the Development of the 4T Program, Jeannine Leverenz, MS, RN, CDCES
  4. Nuances of Socioeconomic Status and Health Insurance Associations with HbA1c in Adults with Type 1 Diabetes, Caitlin Kelly, PhD (virtual)

12:10 – 1:10 pm Lunch


1:10 – 2:10 pm Break Out Session #2

Supporting Device Use (Orchid D)
Facilitated by Sonya Haw, MD

  1. Improving Back-up Planning in the Event of Pump Failure, Victoria Elliot, MD
  2. Standardizing insulin pump therapy initiation
    in children with Type 1 diabetes, Mili Vakharia, APRN, FNP-C (virtual)
  3. Increasing Remote Upload of Insulin Pump Data among Children with Type 1 Diabetes, Andrew Lavik, MD, PhD
  4. Pediatric Type 1 Diabetes Technology Use: Hispanic Caregiver’s Perspective, Mariaester Makacio-Morillo, MD

Building Equity Through SDOH (Orchid C)
Facilitated by Andrea Mucci, MD, MASc

  1. Addressing Social Determinants of Health to Improve Health Outcomes for Patients with Diabetes, Emily Dewit, MASL
  2. Equity in Diabetes Care & Transformation
    Implementation of Social Determinants of Health Screening in Diabetes Clinic, Nana-Hawa Yayah Jones, MD
  3. Implementation of SDOH Screening in Patients with Diabetes: Cook Children’s Endocrinology Clinic, Christin Morell, RN, BSN
  4. Improving SDOH Screening: The HCH Pediatric Diabetes Center at NYU Langone, Jeniece Ilkowitz, RN, MA, CD

Patient Engagement (Orchid B)
Facilitated by Jeff Hitchcock

  1. Improving Mental Health Screening in an Adult Endocrinology Clinic, Denne Mohandas, BA
  2. Improvement in Screening for Depression in Adolescents with Diabetes, Angel Nip, MD (virtual)
  3. Increasing Patient Engagement Through the Use of Online Diabetes Questionnaire, Stephanie Ogburn, RN, BSN, CDCES, Candice Williams, NP
  4. “TechQuity” and Peer Support to Reduce Disparities in Glycemic Outcomes in Children with Type 1 Diabetes (T1D), Jenise Wong, MD, PhD (virtual)

2:15 – 3:15 pm Rapid Insulins and Ultra Rapid Insulins (Brickell)
Halis K Akturk, MD


3:15 – 3:55 pm Travel time to clinic tours

3:55 – 5:00 pm University of Miami Tours
Pediatric Clinic – Adult Clinic & DRI

5:30 pm Shuttle/Metro back to Hyatt


Day Two: Nov 7th, 2022

7:00 – 8:00 am Breakfast

8:00 – 8:15 am Logistics and Welcome (Brickell)
Nicole Rioles, MA

8:15 – 8:45 am Comprehensive Psychosocial Screening Program in a Pediatric Diabetes Clinic (Brickell)
Alan Delamater, PhD

8:50 – 9:50 am Breakout Session #3

Developing Collaborative Infrastructure (Orchid A)
Facilitated by Vana Raman, MD

  1. Scholarly Dissemination from the T1DX-QI Network, 2020 – 2022, Nicole Rioles, MA
  2. Building Capacity for Quality Improvement Among T1D Exchange QI Coordinators, Ori Odugbesan, MD, CPHQ
  3. Review of Common Errors During EMR Data Mapping and
    Transformation to the T1D Exchange QI Data Specification, Anton Wirsch, MS
  4. User Value: Comparisons Between Data-Mapped and Non-Mapped T1D Exchange Quality Improvement Portal Users, Ann Mungmode, MPH, CPHQ

Decision, Support and Care Continuity (Orchid C)
Facilitated by Alissa Guarneri, MD

  1. Artificial Intelligence Decision Support Enhances Engagement and Integration with Home Diabetes Care, Gajanthan Muthuvel, MD (virtual)
  2. Improving Patient Continuity of Care in Pediatric Endocrinology Fellowship, Jonathan Tatum, MD (virtual)
  3. The Diabetes, Data & Devices (D3) Education Program: Motivating Patient-Driven Review of Diabetes Data and Insulin Dose Changes, Ashley Garrity, MPH
  4. Increasing Frequency of Clinic Visits among Medicaid Insured Children and Adolescents with Type 1 Diabetes, Carla Demeterco-Berggren, MD, MPH

Identifying, Delaying and Reducing DKA Admissions & Supporting High-Risk Populations (Orchid D)
Facilitated by Andrew Ahmann, MD

  1. Using Quality Improvement Techniques to Reduce Delayed Hospital Follow-up in Youth with Known T1DM Admitted in DKA, Andie Kaminsky, RN, BSN, CPN, CDCES
  2. A Program to Decrease Diabetic Ketoacidosis (DKA) Admissions:
    Diabetes Wellness Program (DWP)
    Pediatric Diabetes Program, Roberto Izquierdo, MD
  3. Utilization of a CGM-Based Dashboard to Identify At-Risk Patients with Type 1 Diabetes (T1D), Britaney Spartz
  4. Implementation of a Wellness Program for People with Diabetes with HbA1c >9%, Jeniece Ilkowitz, RN, MA, CDCES

9:50 – 10:05 am Break

10:05 – 10:35 am Team-Science Approaches and the Value of Early Screening (Brickell)
Alberto Pugliese, MD

10:40 – 12:00 pm Committee Presentations (Brickell)
Shivani Agarwal, MD, MPH and Shideh Majidi, MD, MDCS Publications
Daniel DeSalvo, MD and Carol Levy, MD, Data Governance
Joyce Lee, MD, PhD and Marina Basina, MD, PhD Data Science
Facilitated by Devin Steenkamp, MBChB and Todd Alonso, MD, Clinical Leadership

QI Champions (Brickell) 
Facilitated by Ori Odugbesan, MD, CPHQ and Ann Mungmode, MPH, CPHQ


12:00 – 1:00 pm Lunch
Ariana and Adrian Rodriguez, patient speaker

1:00 – 2:00 pm Panel Discussion: Advocating for Change (Brickell)
Laurel Koester, MPH, Francesco Vendrame, MD, MPH, Janine Sanchez, MD,
Ori Odugbesan, MD, CPHQ, and Amanda Waks

Facilitated by Osagie Ebekozien, MD, MPH, CPHQ

2:00 – 3:00 pm Breakout Session #4

Health Equity and SDOH (Brickell)
Ori Odugbesan, MD, CPHQ Nana-Hawa Yayah Jones, MD, and Jenise Wong, MD, PhD (virtual)

Behavioral Health, Education & Patient Engagement (Orchid B)
Christy Byer-Mendoza, MSN, RN, CPN, CNS, Cynthia Munoz, PhD, Amy Ohmer

Care Transitions (Orchid D)
Ann Mungmode, Faisal Malik, and Sarah Corathers, MD (virtual)

Technology, Device Use, and TIR/A1C Targets (Orchid C)
Nudrat Noor, PhD, MPH, Mark Clements, MD, PhD, and Francisco Pasquel, MD, MPH (virtual)

Building QI Capacity (Orchid A)
Don Buckingham, MBOE CPHQ, Curtis Yee, BBA (virtual)

3:00 – 3:15 pm Wrap-up Evaluation (Brickell)
Dave Walton, MBA

Program Faculty

The following faculty members have no relevant financial relationships to disclose:

Blake Adams; Andrew Ahmann, MD; Todd Alonso, MD; Maria Basina, MD; Don Buckingham, MBOE, CPHQ; Christine Byer-Mendoza; Emily Coppedge, NP; Sarah Corathers, MD; Alan Delamater, PhD; Victoria Elliott; Donna Eng, MD; Mary Pat Gallagher, MD; Kajal Gandhi, DO, MPH; Ashley Garrity; Alissa Guarneri, MD; Sonya Haw, MD; Jeff Hitchcock; Jeniece Ilkowitz, RN; Robert Izquierdo, MD; Caitlin Kelly, MD; Laurel Koester, MPH; Andrew Lavik, MD; Joyce Lee, MD; Jeannine Leverenz; Brent Lockee; Shideh Majidi; Faisal Malik; Elizabeth Mann, MD; Priyanka Mathias; Brian Miyazaki, MD; Deene Mohandas; Christin Morell; Mariaester Makacio Morillo; Andrea Mucci, MD; Ann Mungmode, MPH; Cynthia Munoz, PhD; Gajanthan Muthuvel, MD; Grace Nelson; Angel Nip, MD; Nudrat Noor, PhD, MPH; Ori Odugbesan, MD, MPH; Stephanie Ogburn; Amy Ohmer; Francisco Pasquel, MD, MPH; Vandana Raman, MD; Robert Rapaport, MD, PhD; Janine Sanchez, MD; Jonathan Tatum; Craig Vandervelden, PhD; Alisha Virani; Amanda Waks, Patient Representative; Candance Williams; Anton Wirsch;

Dr. Agarwal is a consultant for Medtronic Inc. and Beta Bionics. He also receives grant/research support from Dexcom and Abbott.

Dr. Akturk receives grant/research support from Dexcom, Medtronic and Tandem; Is a consultant for Eli Lilly, and is on the Board of Senseonics and Mannkind.

Dr. Carla-Demeterco-Berggren is a speaker for Glooko.

Dr. Clements, is a consultant for Glooko and receives research grant support from Abbott Diabetes Care and Dexcom.

Dr. Desalvo is a consultant and speaker for Dexcom; Receives Grant support from Insulet.

Dr. Ebekozien is a consultant for Medtronic Diabetes and receives grant support from Medtronic Diabetes, Eli Lilly, Dexcom and is a speaker for Vertex.

Dr. Jones is a consultant and speaker for Medtronic.

Dr. Kaminsky is a trainer for Tandem Diabetes pump.

Dr. Levy is a consultant for Dexcom and Lilly, Receives grant/research support from Dexcom, Insulet and Abbott, and Tandem.

Dr. Mckee is a consultant for Medtronic and Novo Nordisk. 

Dr. Pugliese is a consultant for ProventionBio.

Dr. Steenkamp, Director of the Clinical Diabetes Program at Boston Medical Center and Boston University School of Medicine; receives research grant support from Novo Nordisk.

Dr.Vendrame is a consultant for Eli Lilly

Dr. Walton is a consultant for Diatech Diabetes.

Dr. Wong receives grant/research support from Dexcom Inc. and Tandem Diabetes Care.

Off-Label Discussion
Dr. Pugliese does plan on discussing the unlabeled/investigational uses of teplizumab, anti-thymocyte globulin intravenous administration, and aldesleukin.

Program Planning Committee
The following members of the T1D Exchange planning committee have no relevant financial relationships to disclose: 

Emily DeWit, RN, CDE, MASL; Patient Representative
Holly Hardison, BS; Program Manager
Nicole Rioles, MA; Program Manager
Janine Sanchez, MD; Course Director
Naomi Sullivan, RN; Nurse Planner 

CME Project Manager: Michael Burk

ACCME Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and T1D Exchange. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


CNE Accreditation
This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly-provided by by T1D Exchange.

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

Contact Hours: 12.5, of which 8.67 are eligible for pharmacology credit


Available Credit

  • 12.50 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Enduring activity for a maximum of 12.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 12.50 ANCC
    • 8.67 ANCC Pharmacology
  • 12.50 Participation
Please login or register to take this course.